NEW YORK (TheStreet) -- RATINGS CHANGES
AbbVie (ABBV) was downgraded at BMO to market perform from outperform ABBV downgraded to Market Perform from Outperform, said BMO. Stock price reflects high expectations on Hep-C opportunity.
Watch the video below for more of Friday's analysts' actions:PETM) was upgraded at Deutsche Bank to hold from sell. The company is still fundamentally challenged, but the stock has underperformed and has several nonfundamental catalysts that could support shares, Deutsche Bank said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes", which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.